SNP array-based karyotyping: differences and similarities between aplastic anemia and hypocellular myelodysplastic...

Area of Science:

• Hematology
• Genetics
• Oncology

Background:

• Aplastic anemia (AA) involves stem cell pool contraction, potentially leading to oligoclonality.
• Myelodysplastic syndromes (MDS) are characterized by the expansion of a single, aberrant hematopoietic clone.
• Distinguishing between AA and hypocellular MDS (hMDS) can be challenging due to overlapping features.

Purpose of the Study:

• To investigate the presence of cryptic clonal aberrations in patients with AA and hMDS.
• To evaluate the utility of single nucleotide polymorphism arrays (SNP-A) in detecting these aberrations.
• To improve the diagnostic distinction between AA and hMDS.

Main Methods:

• Analysis of 93 AA and 24 hMDS patients using SNP-A arrays alongside routine cytogenetics.
• Combined metaphase and SNP-A karyotyping to enhance detection of chromosomal lesions.
• Serial analysis of a subset of AA patients to track clonal evolution.

Main Results:

• Clonal abnormalities, including copy-neutral loss of heterozygosity (UPD), were identified in 19% of AA and 54% of hMDS cases.
• HLA locus lesions, suggestive of immune escape, were found in 3 AA patients.
• SNP-A detected additional clonal lesions in 36% of hMDS patients with normal routine cytogenetics.
• Persistent genomic lesions in AA patients suggested potential misdiagnosis as hMDS.
• Early clonal evolution was observed in serial AA patient samples.

Conclusions:

• SNP-A is effective in identifying cryptic clonal genomic aberrations in AA and hMDS.
• This technique enhances the ability to differentiate between these bone marrow failure syndromes.
• The findings suggest a potential role for SNP-A in refining diagnoses and understanding disease pathogenesis.